MIBEFRADIL, A NOVEL THERAPY FOR GLIOBLATOMA MULTIFORME: INTERLACED THERAPY IN A MURINE MODEL
Publication
, Journal Article
Keir, ST; Reardon, DA; Saling, JR; Gray, LS; Bigner, DD; Friedman, HS
Published in: NEURO-ONCOLOGY
November 1, 2011
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
November 1, 2011
Volume
13
Start / End Page
108 / 109
Publisher
OXFORD UNIV PRESS INC
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Keir, S. T., Reardon, D. A., Saling, J. R., Gray, L. S., Bigner, D. D., & Friedman, H. S. (2011). MIBEFRADIL, A NOVEL THERAPY FOR GLIOBLATOMA MULTIFORME: INTERLACED THERAPY IN A MURINE MODEL. NEURO-ONCOLOGY, 13, 108–109.
Keir, Stephen T., David A. Reardon, Julia R. Saling, Lloyd S. Gray, Darell D. Bigner, and Henry S. Friedman. “MIBEFRADIL, A NOVEL THERAPY FOR GLIOBLATOMA MULTIFORME: INTERLACED THERAPY IN A MURINE MODEL.” NEURO-ONCOLOGY 13 (November 1, 2011): 108–9.
Keir ST, Reardon DA, Saling JR, Gray LS, Bigner DD, Friedman HS. MIBEFRADIL, A NOVEL THERAPY FOR GLIOBLATOMA MULTIFORME: INTERLACED THERAPY IN A MURINE MODEL. NEURO-ONCOLOGY. 2011 Nov 1;13:108–9.
Keir, Stephen T., et al. “MIBEFRADIL, A NOVEL THERAPY FOR GLIOBLATOMA MULTIFORME: INTERLACED THERAPY IN A MURINE MODEL.” NEURO-ONCOLOGY, vol. 13, OXFORD UNIV PRESS INC, Nov. 2011, pp. 108–09.
Keir ST, Reardon DA, Saling JR, Gray LS, Bigner DD, Friedman HS. MIBEFRADIL, A NOVEL THERAPY FOR GLIOBLATOMA MULTIFORME: INTERLACED THERAPY IN A MURINE MODEL. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2011 Nov 1;13:108–109.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
November 1, 2011
Volume
13
Start / End Page
108 / 109
Publisher
OXFORD UNIV PRESS INC
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences